Best Peptide for Anti-Aging
Epithalon, GHK-Cu, Humanin, MOTS-c & More — Ranked by Longevity Evidence (2026)
Anti-aging peptides span two broad categories: compounds with direct human evidence of telomere lengthening, cellular renewal, or immune restoration (Epithalon, GHK-Cu, Thymosin Alpha-1), and preclinical mitochondrial peptides with compelling animal longevity data (Humanin, MOTS-c). None are FDA-approved for longevity. This guide ranks them by depth of human evidence so you can build an informed protocol — and track every dose in Shotlee.
Top Anti-Aging Peptides — Ranked by Evidence
| Peptide / Compound | Mechanism | Best Human Evidence | Status | Evidence Level |
|---|---|---|---|---|
| Thymosin Alpha-1 | T-cell maturation, NK cell activation, immune aging reversal | Approved in 35+ countries for hepatitis and cancer immunotherapy | Approved (Zadaxin); off-label longevity | ⭐⭐⭐⭐⭐Best |
| GHK-Cu | Copper tripeptide — collagen/elastin synthesis, 1,000+ gene activations | Multiple skin aging RCTs; broad regenerative data | Cosmetic ingredient / research peptide | ⭐⭐⭐⭐ |
| Epithalon | Telomerase activation, telomere lengthening, melatonin regulation | Phase 2: telomere lengthening in elderly subjects | Research peptide | ⭐⭐⭐⭐ |
| NAD+ (NMN/NR) | Sirtuin activation, mitochondrial biogenesis (not a peptide) | Multiple Phase 2 RCTs confirming NAD+ repletion | Dietary supplement | ⭐⭐⭐ |
| Rapamycin (mTOR inhibitor) | mTOR inhibition, autophagy induction (not a peptide) | ITP: lifespan extension in mice; geroscience trials ongoing | Approved (immunosuppressant); off-label longevity | ⭐⭐⭐ |
| BPC-157 | Angiogenesis, tissue regeneration, GI mucosal protection | Animal studies; limited human case data | Research only | ⭐⭐ |
| MOTS-c | Mitochondrial AMPK activation, metabolic regulation | Phase 1 safety trial; strong animal longevity data | Early clinical / research | ⭐⭐ |
| Humanin | Mitochondrial peptide — neuroprotection, apoptosis inhibition | Observational: lower levels in Alzheimer's patients | Research only | ⭐⭐ |
Top Anti-Aging Picks Explained
Epithalon (Epitalon)
A tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal gland extract Epithalamin. Phase 2 research by Khavinson et al. demonstrated telomere lengthening in elderly subjects and improved melatonin secretion. Used in longevity clinics as 10-day courses 1–2x per year. The best-studied peptide specifically for telomere biology in humans.
GHK-Cu (Copper Tripeptide-1)
Naturally occurring plasma peptide that declines with age. Activates over 1,000 genes involved in tissue repair, collagen and elastin synthesis, anti-inflammatory signalling, and antioxidant defence. Multiple RCTs confirm skin aging improvement topically. Systemic injection data is emerging in biohacking protocols. Among the most evidence-backed regenerative peptides available.
Thymosin Alpha-1 (TA-1)
The most clinically established immune-aging peptide. Approved as Zadaxin in 35+ countries for hepatitis B/C and as a cancer immunotherapy adjunct. Restores thymic function and T-cell responses that decline with age. Used off-label in longevity protocols to counter immunosenescence — the age-related immune decline linked to elevated cancer and infection risk.
Humanin
A small peptide encoded within the mitochondrial 16S rRNA gene. Plasma Humanin levels decline with age and are significantly lower in Alzheimer's disease patients and their first-degree relatives. Protects neurons, reduces amyloid-beta toxicity, and extends lifespan in animal models. No Phase 2/3 human intervention trials yet, but observational correlation data is strong.
MOTS-c
Mitochondrial open reading frame of the 12S rRNA-c. Activates AMPK — the same metabolic sensor targeted by metformin — and translocates to the nucleus under metabolic stress. Animal studies show improved insulin sensitivity, obesity resistance, and extended lifespan. A Phase 1 safety trial has been completed. Widely used in advanced longevity protocols despite limited human efficacy data.
NAD+ Precursors (NMN / NR)
Not peptides, but foundational to most longevity stacks. NMN and NR raise intracellular NAD+ levels which decline approximately 50% by age 50. NAD+ is required for sirtuin (SIRT1–7) activity, mitochondrial biogenesis, and DNA repair. Phase 2 RCTs confirm NAD+ repletion in humans. Often combined with Epithalon or MOTS-c in comprehensive longevity protocols.
How to Choose the Right Anti-Aging Peptide
For most people entering the longevity peptide space, the evidence-based starting stack is: Epithalon (telomere maintenance, 1–2 courses per year), GHK-Cu (topical for skin, systemic if injecting), and Thymosin Alpha-1 (immune aging). This combination addresses three independent aging pathways — telomere biology, regenerative signalling, and immunosenescence — and has the strongest human evidence among research peptides.
MOTS-c and Humanin are compelling additions if your focus is metabolic aging or neurodegeneration risk reduction. Both remain at early clinical stages for human longevity specifically. If you are already using metformin or rapamycin, adding MOTS-c may be partially redundant on the AMPK pathway and should be discussed with your physician.
Rapamycin and NAD+ precursors are the best-studied longevity interventions overall — neither is a peptide, but both are commonly combined with peptide protocols in longevity clinics. Work with a longevity medicine physician before combining multiple pathway interventions. Track all compounds in Shotlee to build a personal response dataset over time.
How to Track Your Anti-Aging Protocol in Shotlee
Frequently Asked Questions
Epithalon has the most direct human evidence for telomere lengthening. GHK-Cu has the broadest regenerative evidence base across skin, tissue repair, and gene expression. Thymosin Alpha-1 has the strongest clinical approval record for immune aging. Most longevity protocols combine at least two of these three compounds.
Phase 2 research by the St. Petersburg Institute of Bioregulation showed telomere lengthening in elderly subjects receiving Epithalon vs. controls. The sample sizes are modest by drug trial standards, but it is currently the most direct human telomere-lengthening peptide evidence available. Track your Epithalon courses alongside telomere testing to build your own data.
Both activate AMPK, the master metabolic regulator. Metformin does so primarily via mitochondrial complex I inhibition. MOTS-c is a mitochondrially-encoded peptide that activates AMPK more directly and also has nucleus-targeting effects on gene expression under metabolic stress. Animal data suggests additive effects, but human combination data does not yet exist.
Yes — they act on distinct pathways (telomerase activation vs. copper-dependent gene regulation and regeneration) so they are not redundant. Many longevity practitioners run Epithalon 1–2x per year and use GHK-Cu continuously topically or in periodic injection courses between Epithalon cycles.
Rapamycin requires a prescription in all major jurisdictions and requires physician supervision for off-label longevity use. Side effects at low intermittent doses (1–6 mg weekly) appear mild in published case series, but drug interactions and immune suppression risk are real. Never use rapamycin without medical oversight.
Track Your Anti-Aging Protocol in Shotlee
Log every peptide course, biomarker result, and subjective change. Build the personal longevity dataset that shows you what is actually working.